Navigation Links
Forest Laboratories, Inc. Reports Fiscal Year 2009 Fourth Quarter Reported EPS of $0.31 Including $0.45 Per Share Charge Related to the Ongoing United States Attorney's Office Investigation
Date:4/21/2009

of congestive heart failure, which if approved, will further enhance the sales potential of this already successful recent product launch. By mid-year we expect to report Phase III clinical data for ceftaroline, a broad-spectrum cephalosporin antibiotic with activity against gram-positive bacteria, including MRSA and gram-negative bacteria, for the treatment of community acquired pneumonia (CAP). If the CAP data is positive, we will submit an NDA, together with the positive results that we have already reported for the treatment of complicated skin and skin structure infections, around the end of this calendar year. We are in the process of initiating additional Phase III studies for dutogliptin, for the treatment of Type 2 diabetes mellitus. Also around mid-year we expect to begin Phase III studies for levomilnacipran, for the treatment of depression. We have commenced Phase III studies for linaclotide, for the treatment of chronic constipation and shortly, we expect to begin Phase III trials for the additional indication of constipation predominant irritable bowel syndrome. Linaclotide is a promising novel compound that may offer a much needed therapy for this very large and underserved patient population. Later this year we anticipate receiving Phase II-b data for cariprazine, for the treatment of schizophrenia, and if positive, we expect to initiate Phase III studies for the treatment of patients with acute mania associated with bipolar I disorder. We also expect to receive Phase II clinical data for oglemilast, for the treatment of COPD, later this year.

As is evident from our pipeline of both late and earlier stage products, Forest continues to have access, often preferential access, to the many new compounds initially developed by other companies, some also based in the U.S. and others outside the U.S. Importantly, Forest is viewed as a highly desirable development and marketing partner, often precisely because of our size and past
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
2. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
3. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
4. Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents
5. German Federal Patent Court Invalidates Wake Forest NPWT Patents Licensed to KCI
6. Wake Forest Baptist and Rivulet Connect New Operating Rooms with Interactive Video
7. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM)
8. Forest Laboratories, Inc. Provides Statement in Response to Complaint Filed by U.S. Government
9. United States Files Complaint Against Forest Laboratories for Allegedly Violating the False Claims Act
10. Old-Growth Forests Dying Off in U.S. West
11. Forest Laboratories, Inc. Reports Q309 Diluted Earnings Per Share of $0.62, Including $0.41 Per Share Charge for New Product Licensing Fees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Principle Business Enterprises, a family owned ... top-of-the-line absorbent products. The company has recently made ... brand, Tranquility® Premium Protection absorbent products. The company ... its packaging a new look, and is currently working ... the public. , The new website, developed with Thread ...
(Date:10/20/2014)... Collins, CO (PRWEB) October 20, 2014 ... dGH assays are the only imaging assays capable ... in a single test.  With these three dimensions ... their ability to detect the widest range of ... translocations—mutations usually missed by other genomic tools, including ...
(Date:10/20/2014)... 20, 2014 Punzoné , the first ... U.S., has a lot to celebrate this month. October marks ... the achievements and contributions of Americans of Italian heritage and ... and today it shares its favorite Italian cocktails and encourages ... Italy - even if it is only in a glass. ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 Recently, BambooIndustry.com, ... has unveiled its new range of bamboo deckings ... for these natural items; they are now available at ... most people, it is hard to overstate the significance ... of attention to online services. The company’s workers are ...
(Date:10/19/2014)... 20, 2014 Recently, Fancyflyingfox.com, an innovative ... clothes, has announced its latest designs of 2014 ... the new elegant outfits are offered with big discounts, ... order before October 30 can enjoy this special offer. ... marketing strategies, it has become one of the leading ...
Breaking Medicine News(10 mins):Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2
... order to provide quick relief from post pregnancy depressions, health ... more vulnerable to this type of depression and taken preventive ... the researcher of University of Toronto, Canada who had reviewed ... it is possible to prevent post partum depression but the ...
... twins may be more different from each other than that ... lost over the time that can leave them very different ... in identical twins is the direct result of their epigenome. ... because of its genetic structure, but because of the varied ...
... two human clinical trials support the enhanced bioavailability// ... which will interest manufacturers of CoQ10 products. ... ingredient, allows supplement and food makers to use lower ... technology uses common food-grade emulsifiers and solvents to trap ...
... may play a more dominant role than exercise// for increasing bad ... why some people never gain weight or increase their cholesterol despite ... content!! , ,The July 8, 2005, issue of the ... pairs of identical twins in whom one was a vigorous exerciser ...
... are often treated with inhaled nitric oxide// therapy. A recent ... not reduce the chances of death or further lung infections. ... babies who weigh less than 1.5kgs need not be given ... a study. Inhaled nitric oxide therapy is effective for treating ...
... Nervosa is a condition that usually affects young women and ... is due to overactive dopamine receptors in the basal ganglia ... are driven to be excessively thin and are unaware of ... many will remember the death of the famous talented singer ...
Cached Medicine News:Health News:Genes More Important Than Exercise for Bad Cholesterol 2Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 2Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 3
(Date:10/17/2014)... , October 17, 2014 ... Markets ( http://www.researchandmarkets.com/research/rxznjk/micro_market ) has announced the ... : North American Automated External Defibrillators ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,The report North ... analyzes the market of devices based ...
(Date:10/17/2014)... 2014 Investor-Edge has initiated coverage ... ARNA ), NPS Pharmaceuticals Inc. (NASDAQ: ... Momenta Pharmaceuticals Inc. (NASDAQ: MNTA ), and ... these five companies can be accessed at: http://investor-edge.com/register ... 16, 2014, ended on a mixed note as the ...
(Date:10/17/2014)... KIRKLAND, Wash. , Oct. 17, 2014  Talyst, ... at the 2014 LeadingAge Annual Meeting in ... its InSite System, the market leading solution for onsite, ... enables long term care facilities to safely and securely ... on time to first dose, helps ensure that the ...
Breaking Medicine Technology:Micro Market Monitor : North American Automated External Defibrillators (AED) Market 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 4Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 5Talyst Exhibits at LeadingAge Annual Meeting 2
... N.J., Oct. 8 Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ... 4,300,000 shares of its common stock at a price of ... estimated offering expenses, Savient expects to receive net proceeds of ... sold by Savient. In addition, Savient has granted the ...
... Oct. 8 BALTIMORE CONVENTION CENTER / BOOTH ... of emergency department (ED) clinical documentation solutions, today announced ... ® electronic Emergency Department Information System (EDIS) incorporates ... facilitate the diagnosis and treatment of H1N1, as well ...
Cached Medicine Technology:Savient Pharmaceuticals Prices Underwritten Offering of Common Stock 2Latest Content Release for The T SystemEV EDIS Supports Clinicians in Providing Quality Care for H1N1 Patients 2Latest Content Release for The T SystemEV EDIS Supports Clinicians in Providing Quality Care for H1N1 Patients 3
... For the quantitative determination of ... ,Patients with atopic allergic diseases such ... fever have been shown to exhibit ... blood. IgE is also known as ...
...
...
...
Medicine Products: